AZZI, ALBERTA
 Distribuzione geografica
Continente #
NA - Nord America 5.751
EU - Europa 3.958
AS - Asia 648
AF - Africa 48
OC - Oceania 5
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.414
Nazione #
US - Stati Uniti d'America 5.734
RU - Federazione Russa 1.313
PL - Polonia 796
IE - Irlanda 453
SE - Svezia 451
IT - Italia 374
UA - Ucraina 204
SG - Singapore 199
HK - Hong Kong 163
DE - Germania 121
FI - Finlandia 117
CN - Cina 104
IN - India 77
JO - Giordania 67
GB - Regno Unito 60
CI - Costa d'Avorio 37
FR - Francia 25
TR - Turchia 20
CA - Canada 17
AT - Austria 14
CH - Svizzera 11
VN - Vietnam 10
BE - Belgio 7
SC - Seychelles 5
NL - Olanda 4
AU - Australia 3
BR - Brasile 3
KR - Corea 3
MU - Mauritius 3
SM - San Marino 3
TW - Taiwan 3
ES - Italia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
A1 - Anonimo 1
AZ - Azerbaigian 1
EG - Egitto 1
HR - Croazia 1
SA - Arabia Saudita 1
Totale 10.414
Città #
Santa Clara 982
Warsaw 796
Fairfield 700
Chandler 513
Dublin 452
Woodbridge 335
Jacksonville 321
Ashburn 311
Cambridge 292
Houston 252
Seattle 251
Wilmington 201
Singapore 149
Princeton 126
Ann Arbor 120
Mumbai 76
Boston 72
Florence 71
Hong Kong 66
Medford 66
Kent 61
Boardman 58
Altamura 48
Lawrence 45
Buffalo 43
Abidjan 37
Beijing 36
San Diego 34
Milan 32
Shanghai 30
Norwalk 27
Izmir 20
Moscow 17
Rome 16
Wayne 16
Vienna 14
Hillsboro 12
Toronto 12
Andover 10
Saint Petersburg 10
Los Angeles 9
Dong Ket 8
Falls Church 8
Bari 7
Brussels 7
New York 7
Sesto Fiorentino 7
Brescia 6
Frankfurt Am Main 6
Laurel 6
Phoenix 6
Yubileyny 6
London 5
Romano di Lombardia 5
Ancona 4
Bern 4
Ottawa 4
San Giovanni Valdarno 4
Sovicille 4
Verona 4
Caivano 3
Cinisello Balsamo 3
Fucecchio 3
Fuzhou 3
Kaohsiung 3
Montegiardino 3
Parma 3
Redwood City 3
Reggio Calabria 3
Reggio Nell'emilia 3
Wettingen 3
Altopascio 2
Amandola 2
Barcelona 2
Bologna 2
Carini 2
Cascina 2
Caserta 2
Central 2
Corzano 2
Empoli 2
Horn 2
Leawood 2
Limbiate 2
Melbourne 2
Mola di Bari 2
Naples 2
Negrar 2
Paglieta 2
Pesaro 2
Redmond 2
Rimini 2
Sarno 2
Segrate 2
Seoul 2
Skopje 2
Tappahannock 2
Tunis 2
Turin 2
West Jordan 2
Totale 6.938
Nome #
H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support 272
Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. 259
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 251
Molecular markers of influenza B lineages and clades 250
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). 235
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center 227
Artrite reumatoide e parvovirus B19: osservazioni preliminari 188
Human herpesviruses respiratory infections in patients with acute respiratory distress (ARDS) 136
A real-time reverse transcriptase-polymer chain reaction to evaluate natural history of viral shedding in outpatient children and adolescents with pandemic 2009 influenza A(H1N1). 130
CONFUTAZIONE DI RECENTI IPOTESI ETIOLOGICHE PER LA PITIRIASI ROSEA DI GIBERT. 128
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 127
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 126
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 126
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 124
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 123
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. 119
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. 115
Tissue persistence of parvovirus B19 genotypes in asymptomatic persons 115
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 114
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. 114
Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products. 114
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 112
Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. 109
BK virus regulatory region sequence deletions in a case of human polyomavirus associated nephropathy (PVAN) after kidney transplantation. 108
Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. 108
HA222 polymorphism in Influenza A(H1N1) 2009 isolates from Intensive Care Units and ambulatory patients during three influenza seasons. 107
A FRET based melting curve analysis to detect nucleotide variations in HA receptor-binding site of H5N1 virus. 106
Human parvovirus B19 (B19V) infection in systemic sclerosis patients. 106
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 105
Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. 104
Human parvovirus B19 infection in bone marrow transplantation patients 102
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy. 102
Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. 102
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. 102
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients 101
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals 100
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. 99
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by nested polymerase chain reaction 97
No association between human parvovirus B19 infection and Sjogren's syndrome. 95
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. 95
High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses. 94
TT virus contaminates first-generation recombinant factor VIII concentrates. 93
Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis 92
Polyomavirus BK-specific immunity after kidney transplantation. 91
Parvovirus B19 and systemic sclerosis. 90
Lymphocytopenia as a marker for pandemic influenza A/H1N1 2009 virus infection in children. 89
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. 88
PRESENCE OF TT VIRUS (TTV) DNA IN BONE MARROW CELLS FROM HAEMATOLOGIC PATIENTS 87
Isolation of influenza A(H3N2) virus with "O"-->"D" phase variation. 87
The transfusion-associated transmission of parvovirus B19. 86
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy. 86
Detection of B19 parvovirus infections by dot-blot hybridization assay using a digoxigenin-labelled probe 86
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients 86
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. 85
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 85
Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. 83
Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. 83
Human herpesvirus 8 (HHV-8) DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy blood donors. 83
Cryptococcose disséminée chez le chat. 83
Human parvovirus B19 infection within a family and risk for pregnant women 83
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 83
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 82
Cryptococcose chez le chien: deux cas cliniques. 81
Parvovirus B19 infection in cultured skin fibroblasts from systemic sclerosis patients: a comment on the article of Ray et al. 81
INTRAUTERINE PARVOVIRUS B19 INFECTION: EARLY PRENATAL DIAGNOSIS IS POSSIBLE. 79
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. 79
Multicentre Italian Study Group (MISG) for the standardisation of hepatitis C virus (HCV) PCR. 78
Indagine epidemiologica sull'infezione da parvovirus B19 in diverse categorie 78
Polymerase chain reaction for synthesis of digoxigenin-labelled DNA probe: application to parvovirus B19 and to polyomavirus BK 77
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 76
BKV e HPV nel sarcoma di Kaposi (KS) AIDS correlate 74
aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia 74
Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera 74
Unusual incidence of aplastic Anaemia due to B19 parvovirus infection in renal transplant recipients 74
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 73
Letter to Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated Factor VIII concentrate: the role of human B19 parvovirus 72
NO ASSOCIATION BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND SJÖGREN¿S SINDROME. 71
Use of denaturing gradient gel electrophoresis for human polyomavirus JC sequence analysis. 71
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated Factor VIII concentrate 71
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 71
Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. 69
Cryptococcus infection in immunodepressed subjects 69
Inchiesta sulla diffusione della criptococcosi nei portatori di HIV in Italia 68
Parvovirus B19 and systemic sclerosis 68
Sorveglianza delle infezioni fungine nelle leucemie acute. 67
BK and JC viruses 64
Cytopenia caused by parvovirus in adult ALL patient 64
Parvovirus B19 infection of bone marrow in systemic sclerosis patients 63
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow tranplantation patients 62
Development of a Quantitative Competitive Polymerase Chain Reaction for Human Polyomavirus BK 62
Hemorrahagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia 60
First-generation recombinant factor VIII concentratesare free from viral contaminations? 58
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 57
Presence of TT virus DNA in bone marrow cells from hematologic patients. 52
New influenza virus type A (H1N1), isolated in Florence. 52
Packaging signals in the 5' coding region of influenza virus PA, PB1, and PB2 genes as potential target to develop oligonucleotide based antiviral molecole. 52
Sonda marcata con digossigenina per la ricerca di BKV 51
Rosolia o V malattia? la risposta nella diagnosi di laboratorio 51
Trasmissibilità dell'infezione da parvovirus B19 attraverso il sangue e gli emoderivati 50
Development of new antivirals against the influenza type A viruses based on small RNAs targeting the packaging signal of the polymarases gene coding region. 50
Totale 9.801
Categoria #
all - tutte 26.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.167 0 0 0 0 171 202 173 214 160 88 132 27
2020/2021988 108 63 78 87 36 150 29 82 81 135 62 77
2021/2022619 18 69 15 21 33 31 15 33 43 27 106 208
2022/20231.908 224 226 89 140 163 399 265 100 213 16 51 22
2023/2024617 37 84 123 23 34 32 24 94 9 33 83 41
2024/20252.965 168 551 311 717 1.218 0 0 0 0 0 0 0
Totale 10.476